/*Accordion Page Settings*/

international

99 - Entrepreneurship, Practice Valuation, and Working with Private Equity, an interview with Dr. Andrew Meikle

Are all clinic owners entrepreneurs? Do all physician-owners really have what it takes to successfully run and grow a private practice?

We’ve talked about joining networks, understanding private equity, and entrepreneurship a lot on this podcast, but usually we are talking about high-level practices to get patients in the door and help them convert to treatment. On this episode of Inside Reproductive Health, we get a new perspective, one that focuses on entrepreneurship, best business practices, and what it really takes to grow in our field.

Dr. Andrew Meikle is the Founder and CEO of The Fertility Partners, a company based in Canada that aims to empower and enable fertility clinics by providing collaboration and strategic expertise. Through his experience in other healthcare fields and his current work in the fertility field, Dr. Meikle shares his thoughts on clinic ownership and entrepreneurship, what fertility networks are looking for, and important things to keep in mind when considering joining private equity.

92 - Increasing Access-to-Care for All Patient Populations, an interview with Dr. Marjorie Dixon

Marjorie Dixon is the founder, CEO, and Medical Director of Anova Fertility and Reproductive Health in Toronto, Canada. After completing her training in the States and experiencing what the field was like in her home country of Canada, Dr. Dixon knew she wanted to start a new clinic that used the best technology, provided the best care, and increased access-to-care for the LGBTQI+ population, one that was close to her heart.

On this episode of Inside Reproductive Health, Griffin digs into why Dr. Dixon chose to start her clinic in Toronto and what she does to not only increase the availability of care to all populations, but what she does to make them feel welcome in her practice.

84 - Pivoting Clinic Operations in the COVID-19 Era, an interview with Dr. Yemi Famuyiwa

When COVID-19 entered the United States, it felt like a scramble to figure out what our next steps were as a field. Do operations continue to give patients the best chance of success? Or do the risks outweigh the benefits? Some clinics pivoted quickly, following the ASRM guidelines precisely. And some clinics panicked with feelings of apprehension of stopping treatment altogether.

On this episode of Inside Reproductive Health, Griffin talks to Dr. Oluyemisi (Yemi) Famuyiwa, the leader of a clinic who seemed to be well-prepared for the unknowns of the virus. Dr. Famuyiwa is the founder and director of Montgomery Fertility Center, an independent clinic located in Rockville, Maryland. Dr. Famuyiwa aims to provide state-of-the-art care based on emergent technologies and ongoing research. And this philosophy was truly exposed when COVID-19 first came on the radar.

Her ahead-of-the-game research got her clinic appropriately prepared for the emergence of the virus in her area, keeping volume steady--and even at the highest it has ever been. So what lessons can other clinics take from her experience in the COVID-19 era?

Learn more about Dr. Yemi Famuyiwa and Montgomery Fertility Center by visiting montgomeryfertilitycenter.com.

70 - How HRC Came to be an International Publicly-Traded Fertility Group, an interview with Dr. Bradford Kolb

HRC Fertility is one of the largest providers of Assisted Reproductive Care in the United States. Started in Southern California in 1988, the clinic has grown immensely, serving thousands of patients every year. In 2017, HRC took their success globally, joining forces with Jinxin Fertility and listing on the Hong Kong Exchange. Despite the booming expansion, HRC never forgot its roots: providing quality, personal care for its patients and giving physicians the opportunity to have full control of patient treatment.

On this episode of Inside Reproductive Health, Griffin spoke with Dr. Bradford Kolb, President of HRC Fertility. Dr. Kolb joined the practice in 2001 and worked through the IPO process with his partners, making HRC what it is today. Not only did we talk about the process of going public, but more importantly, we talked about how HRC was able to maintain their patient and physician culture in this rapid phase of growth. He shares the structure of the clinic and what they do to maintain a small practice feel for such a large organization. Plus, Dr. Kolb offers advice for young fellows and physicians entering the world of Reproductive Medicine and what they can do to be successful in the field from both a personal and professional standpoint.

49 - Do the Psychological Effects of Infertility Dictate Patient Decisions? An Interview with Amira Posner

It’s easy to feel like the patient’s journey is confined to the four walls of your clinic, but their journeys extend deep into their lives. Because of this, providing support services, either in your clinic or outside of it, is so important to the mental health of the families you serve. On this episode of Inside Reproductive Health, Griffin talks to Amira Posner, founder of Healing Infertility and the Mind-Body Fertility Group in Toronto, Ontario. With her background in social work and her experience with secondary infertility, Amira set out on a mission to help women going through a similar experience and provide them with the mental health support they need. Together, Griffin and Amira discuss what she does to support her clients and offers advice to providers and support staff on how they can best provide mental health support in their clinics.

47 - Geographical Differences in 3rd Party Reproduction, An Interview with Liz Ellwood

With the introduction of the Assisted Human Reproduction Act in Canada, Canadian clinics and families have been struggling to find quality third-party reproduction partners while remaining in accordance with the law. After going through her own journey and learning the challenges of the process, Liz Ellwood decided to make a difference in the lives of hundreds of Canadian families struggling with infertility by co-founding Fertility Match, an agency that matches families with donors. On this episode of Inside Reproductive Health, Griffin talks to Liz about her story and what she is doing to make the third-party reproductive process easier on families in Canada.

To learn more about Liz Ellwood, Fertile Future, and how you can help, visit www.fertilefuture.ca.

Want to learn more about Fertility Match? Visit them at www.fertilitymatch.ca.

The details of the Canadian Assisted Human Reproduction Act can be found at https://laws-lois.justice.gc.ca/eng/act/a-13.4/

To get started on a marketing plan for your company, complete the Goal and Competitive Diagnostic at FertilityBridge.com.

39 - Can Geographic Location Have An Impact on Fertility Success? An Interview with Dr. Alex Quaas

But think of the differences across the world--it’s hard to fathom! On this episode of Inside Reproductive Health, Griffin Jones and Dr. Alex Quaas give us a glimpse into (literally) the world of fertility. Having practiced in numerous states and countries, Dr. Quaas shares his experiences, diving into the biggest differences in care he witnessed in Europe and here in the USA.

29 - What is shifting the entrepreneurial landscape for incoming REIs? Rhonda Zwingerman, MD

In this episode, Griffin hosts Dr. Rhonda Zwingerman, a fellow OB-GYN and REI at the Royal Surgeons of Canada and an assistant professor of OB-GYN at the University of Toronto. Jones and Dr. Zwingerman talk about the factors shifting the entrepreneurial landscape for incoming REIs including the funding of fertility treatments, the recruiting of REIs, and the risks involved. Tune in to find out more!

28 - Can IVF or Egg Freezing Vacations Abroad Reduce Stress or Financial Woes? An Interview with Joseph Davis, MD

In this episode, Griffin hosts Dr. Joseph Davis, a Reproductive Endocrinologist who saw the need for a fertility clinic in the Cayman Islands and brought his years of experience working in US clinics and his passion for global health policy to a country that never before had this field of medicine. Jones and Davis chat about the world of fertility past the borders of the United States, discussing not only the access to care issues in other countries, but also the traveling of patients from the US to other countries to seek more affordable options, find privacy, or simply relax during the process.

22 - Benefits and Barriers of International Fertility Care. An Interview with Lori Whalen, R.N.

In this episode, host Griffin Jones speaks to Lori Whalen, a RN who currently works at HRC in Southern California as the international IVF coordinator. Whalen speaks across the country about topics such as compassion fatigue, so Jones invited her to discuss the intricacies related to international IVF as well as the ways to combat the compassion fatigue that often accompanies this high-pressure field.

What Canadian Fertility Centres Need to Know About the Law and Digital Media

By Griffin Jones

A patient’s health information is sacred and a fertility practice’s community of adoring supporters is invaluable. In a world where social media and communication technology develop years ahead of the law, how do we safeguard both privacy and engagement without sacrifice to one or the other? I have interviewed several attorneys regarding the Health Information Portability and Accountability Act (HIPAA) and other regulatory schemes in the United States, but I’ve yet to investigate the law relevant to you, the leaders in reproductive health across Canada.

Dr. Alan West

Dr. Alan West

That is, until now. Dr. Alan West is a physician and a partner at the law firm of Gowling WLG in Toronto. He specializes in healthcare advertising law. Mr. Evan Atwood is a senior associate at the same office who specializes in consumer and healthcare privacy law. You should always consult an attorney for specific legal advice, which Dr. West and Mr. Atwood do not give here, but they offer us some education about how the law can pertain to a Canadian fertility clinic’s internet presence.

Federal and provincial regulations

“We don’t have HIPAA. My head spins when I have to deal with HIPAA.” West clarifies. “We have a mix of federal and provincial laws”. Canada’s PIPEDA (Personal Information Protection and Electronic Documents Act), applies to health information as well as consumer information and applies only in provinces that haven’t passed their own statutes with privacy protections equivalent to those contained in the federal statute. .

Several provinces, including British Columbia and Ontario, have their own health privacy laws. In Ontario, the law is called PHIPA (the Personal Health Information Protection Act).  Atwood explains, “Both fortunately and unfortunately, the law does not explicitly state what information is prohibited from being released without authorization.” Unlike HIPAA in the United States, which has a data set of 18 identifying factors (name, date of birth, license plate number, etc.) for Protected Health Information (PHI), there is no concept of a data set in Canadian privacy law. The principles are much more general.

HIPAA’s 2013 Omnibus rule, adds liability to “business associates”, those who receive and send PHI to “covered entities” (healthcare providers). The obligations of a business associate are explicit. Again, in Canada, the law is not as specific, but the health records custodian (you, the fertility centre) is obliged to see that its vendors only store that data on behalf of the health records custodian, with the same protections in place.  

“The law is always behind the actual practice of medicine.”

Mr. Evan Atwood

Mr. Evan Atwood

In some provinces, medical practices are prohibited from mentioning the brand names of pharmaceuticals and devices in their advertisements. The regulation of marketing falls more on the practices than on the drug companies. “Doctors are allowed to advertise their own services, but they are not supposed to identify or associate themselves with specific products or drugs. Although many do so.” West finds. West and Atwood point to the example of “physician locators”, search engines within pharmaceutical or manufacturer websites, that list nearby physician offices who administer their products. These websites may be impermissibly marketing directly to the consumer, but “I know of no prosecution for using brand names in advertising,” West says.

West offers some insight as to why there is a lack of enforcement of some laws in healthcare advertising. Provincial boards of medical examiners have limited resources, and they spend their attention on investigating serious cases of fraud and malpractice, not on the use of brand names in advertising, which in some instances, have found their way into the public vernacular. In some provinces, there is no obligation to investigate every complaint that is reported to the provincial board. In others, such as Ontario, the board is obliged to investigate every written complaint. They might not take an enforcement action, but the risk is higher because they have to at least open the file.

This is important to know, because what is permissible in one province, may be prohibited by another province’s advertising law. In Ontario for instance, under the Medicine Act, patient testimonials are not permissible. Nonetheless, some medical practices may include testimonials on their websites, including some fertility centres. Whether you use testimonials on your website or not, what about the content posted by a patient to your Facebook or Google Places profile? In that case, it might be advisable not to solicit reviews. “It might not be the intent of the law, but I would rather be the prosecuting attorney than the defendant in such a scenario,” West opines. “As the law is written, I think the doctor has an obligation to police the postings on his or her social media channel”.

“The law has not caught up to reality, to put it mildly”, Atwood adds. “Still, there’s never been a prosecution for what a patient has put on a provider’s social media channel”.

Digital Media and Privacy Law

This wisdom comes with regard to provinces with regulations prohibiting patient testimonials, not with regard to health privacy. Consent is implied when a patient posts his or her own information on a clinic’s blog or social media channel. The doctor can leave it on their site. “Doctors and practices are allowed to respond to reviews and comments because the patient waives his or her right to privacy when they post their own information” West says.

“Implied consent has limits,” Atwood cautions. “You can’t take that content and use it somewhere else”. Failing to obtain the proper consent is a mistake that Atwood and West commonly see. Though Canadian law does not specify six core elements for what is required in an authorization (as in HIPAA), expressed, written consent should be obtained whenever you use patient information outside of what is specified in the law.

West leaves us with a bit of caution. While provincial boards have not yet enforced certain regulations, such as those against the use of brand names in physician advertising, he believes punitive measures could be likely in the future. “Be forewarned of enforcement action. That may be something we see quite a bit more.”

Get specific legal advice

In every country, the technologies and media that people use to communicate develop much more rapidly than the laws that regulate them. We have to engage our online communities in a way that respects patient privacy and also complies with the law. In my opinion, Canada’s laws seem to follow common sense more so than the ambiguity of other regulatory schemes, but I’m not an attorney. I recommend you always consult an attorney about the federal, provincial, and local regulations specific to your area.

Dr. Alan West is a partner in Gowling WLG's Toronto office, practicing primarily in areas of law related to pharmaceuticals and health care.

Mr. Evan Atwood is a senior associate at Gowling WLG’s Toronto office, with experience in guiding clients with advertising compliance issues with Health Canada.